AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Debt History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Debt | ₹4,862 Cr | ₹2,373 Cr | ₹4,972 Cr | ₹5,562 Cr | ₹6,967 Cr |
What is the latest Total Debt ratio of AUROBINDO PHARMA ?
Year | Total Debt |
---|---|
Mar2023 | ₹4,862 Cr |
Mar2022 | ₹2,373 Cr |
Mar2021 | ₹4,972 Cr |
Mar2020 | ₹5,562 Cr |
Mar2019 | ₹6,967 Cr |
How is Total Debt of AUROBINDO PHARMA Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2023 | ₹4,862 Cr | 104.89 | |
Mar2022 | ₹2,373 Cr | -52.28 | |
Mar2021 | ₹4,972 Cr | -10.60 | |
Mar2020 | ₹5,562 Cr | -20.16 | |
Mar2019 | ₹6,967 Cr | - |
Compare Total Debt of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹67,536.7 Cr | 1.9% | 3.6% | 87.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 1.9% |
3.6% |
87.2% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses